Showing results (311-320 of 1,183) with videos related to
Sort By:
Pageof 119
The Journal of Experimental Medicine|November 14, 1997
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytesC C Delibrias, J E Floettmann, M Rowe, et al.Pharmaceutical Research|February 1, 1989
The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorptionM A Hussain, A B Shenvi, S M Rowe, et al.Oncogene|February 2, 1995
The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domainD S Huen, S A Henderson, D Croom-Carter, et al.Current Drug Safety|August 12, 2008
Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and childrenNorberto Krivoy, Erica Hoffer, Yael Lurie, et al.Annals of Plastic Surgery|June 27, 2008
Acquired immune deficiency syndrome and systemic lupus erythematosis: potential causes of surgical emergencies of the handJohnny J Wirth, Kedambady P Sheka, Anup Gheewala, et al.Pharmaceutical Research|May 30, 2002
Kinetics and mechanism of hydrolysis of efavirenzMichael B Maurin, Susan M Rowe, Karl Blom, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Fertility after treatment for Hodgkin's diseaseZ Blumenfeld, E Dann, I Avivi, et al.Seminars in Hematology|September 6, 2002
Future clinical implications for farnesyltransferase inhibitors in hematologic malignanciesHagop M Kantarjian, Jorge E Cortes, Jacob M Rowe, et al.European Journal of Immunology|March 1, 1990
Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cellsR J Murray, J M Brooks, A B Rickinson, et al.Current Opinion in Pharmacology|November 14, 2017
The therapeutic potential of CFTR modulators for COPD and other airway diseasesGeorge M Solomon, Lianwu Fu, Steven M Rowe, et al.Pageof 119